Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
Clinical trial NCT02133664 · COMPLETED
Trial details
- NCT number
- NCT02133664
- Sponsor
- Oregon Health and Science University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-05-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.